Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and tolerability of oral Tonapofylline (Adentri) in heart failure with renal insufficiency
2007-005721-30Phase 2Terminated
- Sponsor
- Biogen
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) and Renal Insufficiency (RI) comparing Tonapofylline (Adentri) with Placebo (2 arms). Primary endpoint: Primary safety and tolerability endpoint. Started Jun 2009; status: terminated.
02
Drugs
Adentri
03
Conditions
heart failure (HF)Renal Insufficiency (RI)
Beyond the preview
Go deeper on 2007-005721-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005721-30.